The Enterprise Value as of November 2024 (TTM) for Viking Therapeutics, Inc. (VKTX) is 5.81B

According to Viking Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.81B. This represents a change of 1.61% compared to the average of 5.72B of the last 4 quarters.

Viking Therapeutics, Inc. (VKTX) Historical Enterprise Value (quarterly & annually)

How has VKTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Viking Therapeutics, Inc. over the last ten years is 426.04M. The current 5.81B Enterprise Value has changed 136.30% with respect to the historical average. Over the past ten years (40 quarters), VKTX's Enterprise Value was at its highest in in the March 2024 quarter at 8.03B. The Enterprise Value was at its lowest in in the March 2016 quarter at 11.98M.

Viking Therapeutics, Inc. (VKTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Viking Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Viking Therapeutics, Inc. (VKTX) Average Enterprise Value

How has VKTX Enterprise Value performed in the past?

The current Enterprise Value of Viking Therapeutics, Inc. (VKTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Viking Therapeutics, Inc. (VKTX) Enterprise Value vs. Peers

How is VKTX’s Enterprise Value compared to its peers?

Viking Therapeutics, Inc.’s Enterprise Value is greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than Terns Pharmaceuticals, Inc. (222.97M), greater than Akero Therapeutics, Inc. (2.00B), less than Reata Pharmaceuticals, Inc. (6.64B), less than Madrigal Pharmaceuticals, Inc. (7.46B), less than Sarepta Therapeutics, Inc. (12.11B), greater than Hepion Pharmaceuticals, Inc. (5.35M), greater than PTC Therapeutics, Inc. (3.21B), greater than Axsome Therapeutics, Inc. (4.65B), less than ImmunoGen, Inc. (8.19B), greater than Seres Therapeutics, Inc. (158.02M), greater than Day One Biopharmaceuticals, Inc. (963.46M), greater than X4 Pharmaceuticals, Inc. (38.44M), greater than Inozyme Pharma, Inc. (202.73M), greater than Acumen Pharmaceuticals, Inc. (139.19M), greater than Mereo BioPharma Group plc (496.22M), greater than AVROBIO, Inc. (-85302404.00), greater than CohBar, Inc. (-4477266.00), greater than Ocean Biomedical, Inc. (35.97M), greater than Enveric Biosciences, Inc. (202.96K), greater than Elevation Oncology, Inc. (18.49M),

Build a custom stock screener for Viking Therapeutics, Inc. (VKTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viking Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Viking Therapeutics, Inc. (VKTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Viking Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.